Modifications

== Les victimes du business de l'amygdaline ==

== Les victimes du business de l'amygdaline ==

Chad Green avait développé une leucémie lymphocytaire aiguë (ALL) à l'âge de 2 ans. Bien qu'il ait été rapidement mis en rémission avec une chimiothérapie, ses parents lui ont fait commencer une «thérapie métabolique» administrée par une sorte de médecin métabolique. Quand Chad a développé des signes de toxicité au cyanure, les autorités du Massachusetts l'ont placé sous tutelle judiciaire pour le traitement seulement. Ses parents ont alors intenté une procédure pour que la «thérapie métabolique» soit rétablie. Quand la court s'est prononcée contre eux, ils ont fui avec Chad au Mexique, où il a été traité par le docteur Contreras. Plusieurs mois plus tard, Chad est décédé d'une  suggérant un empoisonnement au cyanure. Le Dr Contreras a déclaré que le garçon était mort de leucémie, mais que c'était un bon exemple de l'efficacité du Laetrile parce qu'il était mort d'une mort agréable! <ref>Brant J, Graceffa J: Rutherford, Priviteria, and Chad Green: Laetrile's setbacks in the courts. Am J Law Med. 1980 Summer;6(2):151-71 (Le document n'est plus accessible)</ref> <ref>https://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/laetrile.html [...] By 1974, Dr. Contreras stated that he was seeing 100-120 new patients per month, with many more patients returning to obtain additional Laetrile. Patients typically were charged $150 for a month's supply. Contreras acknowledged that few of his cancer patients were "controlled" with Laetrile. While admitting that 40% of the patients displayed no response, he claimed that 30% showed "most definite responses" to the drug. However, these statistics may not be reliable. In 1979, he claimed to have treated 26,000 cancer cases in 16 years. Yet when asked by the FDA to provide his most dramatic examples of success, Contreras submitted only 12 case histories. Six of the patients had died of cancer, one had used conventional cancer therapy, one had died of another disease after the cancer had been removed surgically, one still had cancer, and the other three could not be located. [...] As Laetrile became newsworthy, several cancer victims treated with it drew widespread media scrutiny. One was Chad Green, who developed acute lymphocytic leukemia at age 2. Although he was rapidly brought into remission with chemotherapy, his parents started him on "metabolic therapy" administered by a Manner Metabolic Physician. When Chad developed signs of cyanide toxicity, Massachusetts authorities had him declared a ward of the court for treatment purposes only. His parents then brought suit to reinstitute "metabolic therapy." When the court ruled against them, they fled with Chad to Mexico, where he was treated by Dr. Contreras. Several months later Chad died in a manner suggestive of cyanide poisoning. Dr. Contreras stated that the boy had died of leukemia, but was a good example of the effectiveness of Laetrile because he had died a pleasant death! Chad's parents stated that he had become very depressed because he missed his grandparents, his friends and his dog. [...]

Chad Green avait développé une leucémie lymphocytaire aiguë (ALL) à l'âge de 2 ans. Bien qu'il ait été rapidement mis en rémission avec une chimiothérapie, ses parents lui ont fait commencer une «thérapie métabolique» administrée par une sorte de médecin du métabolisme. Quand Chad a développé des signes de toxicité au cyanure, les autorités du Massachusetts l'ont placé sous tutelle judiciaire pour le traitement seulement. Ses parents ont alors intenté une procédure pour que la «thérapie métabolique» soit rétablie. Quand la court s'est prononcée contre eux, ils ont fui avec Chad au Mexique, où il a été traité par le docteur Contreras. Plusieurs mois plus tard, Chad est décédé d'une  suggérant un empoisonnement au cyanure. Le Dr Contreras a déclaré que le garçon était mort de leucémie, mais que c'était un bon exemple de l'efficacité du Laetrile parce qu'il était mort d'une mort agréable! <ref>Brant J, Graceffa J: Rutherford, Priviteria, and Chad Green: Laetrile's setbacks in the courts. Am J Law Med. 1980 Summer;6(2):151-71 (Le document n'est plus accessible)</ref> <ref>https://www.quackwatch.org/01QuackeryRelatedTopics/Cancer/laetrile.html [...] By 1974, Dr. Contreras stated that he was seeing 100-120 new patients per month, with many more patients returning to obtain additional Laetrile. Patients typically were charged $150 for a month's supply. Contreras acknowledged that few of his cancer patients were "controlled" with Laetrile. While admitting that 40% of the patients displayed no response, he claimed that 30% showed "most definite responses" to the drug. However, these statistics may not be reliable. In 1979, he claimed to have treated 26,000 cancer cases in 16 years. Yet when asked by the FDA to provide his most dramatic examples of success, Contreras submitted only 12 case histories. Six of the patients had died of cancer, one had used conventional cancer therapy, one had died of another disease after the cancer had been removed surgically, one still had cancer, and the other three could not be located. [...] As Laetrile became newsworthy, several cancer victims treated with it drew widespread media scrutiny. One was Chad Green, who developed acute lymphocytic leukemia at age 2. Although he was rapidly brought into remission with chemotherapy, his parents started him on "metabolic therapy" administered by a Manner Metabolic Physician. When Chad developed signs of cyanide toxicity, Massachusetts authorities had him declared a ward of the court for treatment purposes only. His parents then brought suit to reinstitute "metabolic therapy." When the court ruled against them, they fled with Chad to Mexico, where he was treated by Dr. Contreras. Several months later Chad died in a manner suggestive of cyanide poisoning. Dr. Contreras stated that the boy had died of leukemia, but was a good example of the effectiveness of Laetrile because he had died a pleasant death! Chad's parents stated that he had become very depressed because he missed his grandparents, his friends and his dog. [...]</ref>

Joseph Hofbauer était un enfant de neuf ans de New York, qui avait un lymphome de Hodgkin. Ses parents ont refusé les thérapies conventionnelles et également opté pour Laetrile. Le tribunal compétant a refusé de retirer la garde aux parents. L'enfant est mort deux ans plus tard. Aussi bien ALL, comme aussi le lymphome de Hodgkin, sont considérées comme des cancers qui sont traités avec succès.

Joseph Hofbauer était un enfant de neuf ans de New York, qui avait un lymphome de Hodgkin. Ses parents ont refusé les thérapies conventionnelles et également opté pour Laetrile. Le tribunal compétant a refusé de retirer la garde aux parents. L'enfant est mort deux ans plus tard. Aussi bien ALL, comme aussi le lymphome de Hodgkin, sont considérées comme des cancers qui sont traités avec succès.